BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 6157622)

  • 1. Therapy of non-Hodgkin's lymphomas in relapse.
    Klener P; Donner L
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1980; 107(1):36-40. PubMed ID: 6157622
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of relapsed aggressive lymphomas: regimens with and without high-dose therapy and stem cell rescue.
    Hagemeister FB
    Cancer Chemother Pharmacol; 2002 May; 49 Suppl 1():S13-20. PubMed ID: 12042984
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Results of combination chemotherapy of non-Hodgkin's lymphoma.
    Schein PS; Chabner BA; Canellos GP; Young RD; Berard C; DeVita VT
    Br J Cancer Suppl; 1975 Mar; 2():465-73. PubMed ID: 1101932
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Combination chemotherapy and synchronization therapy in lymphogranulomatosis and non-Hodgkin's lymphomas].
    Klein HO
    Hamatol Bluttransfus; 1976; 18():135-45. PubMed ID: 786808
    [No Abstract]   [Full Text] [Related]  

  • 5. [Adriamycin for the treatment of non HOdgkin's lymphomas (author's transl)].
    Parlier Y; Gorin NC; Stachowiak J; Najman A; Duhamel G
    Sem Hop; 1981 Nov 8-25; 57(41-42):1685-90. PubMed ID: 6272402
    [TBL] [Abstract][Full Text] [Related]  

  • 6. VP-16-213 in combination with cyclophosphamide, doxorubicin, vincristine, and prednisone in the treatment of non-Hodgkin's lymphomas.
    Hansen MM; Bloomfield CD; Jørgensen J; Ersbøll J; Pedersen-Bjergaard J; Blom J; Nissen NI
    Cancer Treat Rep; 1980; 64(10-11):1135-7. PubMed ID: 7459900
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemotherapy of non-Hodgkin's lymphomas: Eastern Cooperative Oncology Group experience.
    Bennett JM; Lenhard RE; Ezdinli E; Johnson GJ; Carbone PP; Pocock SJ
    Cancer Treat Rep; 1977 Sep; 61(6):1079-83. PubMed ID: 71207
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combined cyclophosphamide vincristine, procarbazine, and prednisone (COPP) therapy of malignant lymphoma. Evaluation of 190 patients.
    Morgenfeld MC; Pavlovsky A; Suarez A; Somoza N; Pavlovsky S; Palau M; Barros CA
    Cancer; 1975 Oct; 36(4):1241-9. PubMed ID: 1100220
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Curative aspects of modern combination chemotherapy in generalized malignant lymphomas].
    Viollier AF; Senn HJ
    Schweiz Med Wochenschr; 1976 May; 106(22):730-42. PubMed ID: 996491
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combination chemotherapy with cyclophosphamide, vincristine, and prednisone in advanced non-Hodgkin's lymphomas.
    Portlock CS; Rosenberg SA
    Cancer; 1976 Mar; 37(3):1275-82. PubMed ID: 1260652
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of non Hodgkin's lymphoma with "PROVECIP" (procarbazine, vinblastine, cyclophosphamide and prednisone).
    Mandelli F; Biagini C; Baroni CD; Bosman C; Anselmo AP; de Luca AM; Granati L; Petti N; Papa G
    Haematologica; 1980 Feb; 65(1):107-18. PubMed ID: 6768646
    [No Abstract]   [Full Text] [Related]  

  • 12. [Comparative study of two drug combination in non-Hodgkin's lymphoma (author's transl)].
    Somoza N; Morgenfeld MC; Magnasco J; Pavlovsky S; Cavagnaro FJ; Saslavsky J; de Maria H; Macchi A; Suárez A
    Sangre (Barc); 1978; 23(4):418-25. PubMed ID: 705564
    [No Abstract]   [Full Text] [Related]  

  • 13. The non-Hodgkin's lymphomas: a review.
    Golomb HM; Moran EM; Ultmann JE
    Rev Bras Pesqui Med Biol; 1974; 7(2):123-31. PubMed ID: 4605305
    [No Abstract]   [Full Text] [Related]  

  • 14. Secondary amenorrhea after Hodgkin's lymphoma is influenced by age at treatment, stage of disease, chemotherapy regimen, and the use of oral contraceptives during therapy: a report from the German Hodgkin's Lymphoma Study Group.
    Behringer K; Breuer K; Reineke T; May M; Nogova L; Klimm B; Schmitz T; Wildt L; Diehl V; Engert A;
    J Clin Oncol; 2005 Oct; 23(30):7555-64. PubMed ID: 16234521
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Chemotherapy of malignant lymphomas].
    Hartwich G; Neidhardt B
    Fortschr Med; 1978 Jun; 96(22):1155-9. PubMed ID: 350740
    [No Abstract]   [Full Text] [Related]  

  • 16. [Combination chemotherapy for advanced diffuse non-Hodgkin's lymphomas in relapse following local radiotherapy].
    Sampi K; Honda T; Hattori M
    Rinsho Hoshasen; 1983 Jun; 28(6):673-7. PubMed ID: 6688641
    [No Abstract]   [Full Text] [Related]  

  • 17. Effect of splenectomy on tolerance to combination chemotherapy in patients with lymphoma.
    Ihde DC; DeVita VT; Canellos GP; Young RC
    Blood; 1976 Feb; 47(2):211-22. PubMed ID: 1244920
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Chemotherapy of non-Hodgkin lymphomas].
    Schoengen A
    MMW Munch Med Wochenschr; 1980 Oct; 122(44):1539-44. PubMed ID: 6779111
    [No Abstract]   [Full Text] [Related]  

  • 19. Combined therapy with rituximab plus cyclophosphamide/doxorubicin/vincristine/prednisone (CHOP) for Sjögren's syndrome-associated B-cell aggressive non-Hodgkin's lymphomas.
    Voulgarelis M; Giannouli S; Anagnostou D; Tzioufas AG
    Rheumatology (Oxford); 2004 Aug; 43(8):1050-3. PubMed ID: 15187246
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 14-day variant of the bleomycin, etoposide, doxorubicin, cyclophosphamide, vincristine, procarbazine, and prednisone regimen in advanced-stage Hodgkin's lymphoma: results of a pilot study of the German Hodgkin's Lymphoma Study Group.
    Sieber M; Bredenfeld H; Josting A; Reineke T; Rueffer U; Koch T; Naumann R; Boissevain F; Koch P; Worst P; Soekler M; Eich H; Müller-Hermelink HK; Franklin J; Paulus U; Wolf J; Engert A; Diehl V;
    J Clin Oncol; 2003 May; 21(9):1734-9. PubMed ID: 12721249
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.